Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance

Publisher:
Nature Publishing Group
Publication Type:
Journal article
Citation:
Bryant, C et al. 2013, 'Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance', Blood Cancer Journal, vol. 3, no. 1, pp. e148-1-e148-7.
Issue Date:
2013
Full metadata record
Files in This Item:
Filename Description Size
2013001042OK.pdf2.02 MB
Adobe PDF
Despite improved outcomes in multiple myeloma (MM), a cure remains elusive. However, even before the current therapeutic era, 5% of patients survived >10 years and we propose that immune factors contribute to this longer survival. We identified patients
Please use this identifier to cite or link to this item: